After gastric bypass surgery, the body produces more satiating hormones, which is a key reason for its effectiveness. Ozempic mimics these hormones, helping people feel less hungry and lose weight, but it was originally approved for diabetes management. The surge in demand for weight loss has contributed to a shortage of the drug, raising concerns about its availability for those who truly need it for diabetes.
